Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

Risultato della ricerca: Contributo su rivista › Editoriale

Accesso al documento

@article{2855d8c22ffd44998a5b3a5d9496d781,

title = "Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response",

keywords = "Circulating molecular marker, ctDNA (circulating tumor DNA), liquid biopsy, personalized medicine, precision oncology",

author = "Gloria Ravegnini and \{Del Re\}, Marzia and Grolla, \{Ambra A.\} and \{van Schaik\}, \{Ron H.N.\} and Sabrina Angelini",

year = "2020",

month = oct,

day = "7",

doi = "10.3389/fphar.2020.598261",

language = "English",

volume = "11",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

}

TY - JOUR

T1 - Editorial

T2 - Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

AU - Ravegnini, Gloria

AU - Del Re, Marzia

AU - Grolla, Ambra A.

AU - van Schaik, Ron H.N.

AU - Angelini, Sabrina

PY - 2020/10/7

Y1 - 2020/10/7

KW - Circulating molecular marker

KW - ctDNA (circulating tumor DNA)

KW - liquid biopsy

KW - personalized medicine

KW - precision oncology

UR - https://www.scopus.com/pages/publications/85094104409

U2 - 10.3389/fphar.2020.598261

DO - 10.3389/fphar.2020.598261

M3 - Editorial

SN - 1663-9812

VL - 11

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 598261

ER -